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Abstract
Background: Trace elements have been hypothesised to be involved in the pathogenesis of Multiple Sclerosis and volcanic
degassing is the major natural sources of trace elements. Both incidence of Multiple Sclerosis in Catania and volcanic activity
of Mount Etna have been significantly increased during the last 30 years. Due to prevailing trade winds direction, volcanic
gases from Etna summit craters are mostly blown towards the eastern and southern sectors of the volcano.
Objective: To evaluate the possible association between Multiple Sclerosis and exposure to volcanogenic trace elements.
Methods: We evaluated prevalence and incidence of Multiple Sclerosis in four communities (47,234 inhabitants) located in
the eastern flank and in two communities (52,210 inhabitants) located in the western flank of Mount Etna, respectively the
most and least exposed area to crater gas emissions.
Results: A higher prevalence was found in the population of the eastern flank compared to the population of the western
one (137.6/100,000 versus 94.3/100,000; p-value 0.04). We found a borderline significantly higher incidence risk during the
incidence study period (1980–2009) in the population of the eastern flank 4.6/100,000 (95% CI 3.1–5.9), compared with the
western population 3.2/100,000 (95% CI 2.4–4.2) with a RR of 1.41 (95% CI 0.97–2.05; p-value 0.06). Incidence risks have
increased over the time in both populations reaching a peak of 6.4/100,000 in the eastern flank and of 4.4/100.000 in the
western flank during 2000–2009.
Conclusion:We found a higher prevalence and incidence of Multiple Sclerosis among populations living in the eastern flank
of Mount Etna. According to our data a possible role of TE cannot be ruled out as possible co-factor in the MS pathogenesis.
However larger epidemiological study are needed to confirm this hypothesis.
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Introduction
The geographic and temporal variations in the frequency of MS
have been intensively studied. In the past, a latitudinal distribution
of MS, with a north-to-south gradient, constituted one of its
epidemiological hallmarks [1]. A recent systematic review of
incidence studies of MS has underlined an attenuation of the
latitude gradient in MS incidence over the last 25 years,
apparently as a result of increased incidence of MS in regions
closer to the equator [2]. Several epidemiological studies have
been also carried out in Mediterranean countries suggesting a
more complex distribution [3]. Concerning the MS distribution in
Italy, incidence has steeply increased over the time in several areas
[4–8], even if in others it has remained stable over the time [9] or
increased only for a certain period [10–11]. Considering only
more recent studies, incidence rates reported in continental Italy
are on average about 4.0–5.0 cases per 100,000 per year
[4,5,8,9,10], while higher incidence risks have been generally
reported in Sardinia and Sicily [6,7,11]. In the city of Catania,
incidence has been increasing dramatically during the last 30
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years, reaching a peak of 7.0/100,000 during 2000–2004 and, on
the basis of the latter estimate, Sicily, along with Sardinia, can be
considered the area with the highest risk among the Mediterra-
nean populations [11,12–14].
MS is currently considered a multi-factorial disease, probably
due to a complex interaction between susceptible genes and one or
more environmental triggers [15]. Among the environmental
factors, either excess or deficiency of trace elements (TE) have
been hypothesised to be involved in the pathogenesis of various
neurologic diseases, including MS [16,17]. Even if there are
several sources of TE in everyday life, volcanoes with their
degassing represent the major natural source [18,19]. Volcano-
genic TE are highly toxic in relation both to their concentration
and to their redox state and can have serious effects on the
environment and on public health in the cities located around an
active volcano, as they accumulate in soils, plants and ground
waters used for drinking purposes. Mount Etna is the largest active
volcano in Europe, emitting a large amount of gases and hence of
heavy and alkali metals [19,20]. Volcanic activity at Mount Etna
has increased significantly during the last decades [21,22],
therefore may be reasonable to assume an increasing impact of
TE on the populations living at the foot of the volcano. Due to the
prevailing westerly to north-westerly trade winds in the Mount
Etna region [19,23], most of the times the volcanic gases from the
summit craters are blown to the Eastern and Southern sectors of
the volcano. As a matter of fact, in these highly exposed areas,
where also rainfall is higher than in the rest of the volcano, the
content of TE in plants and in lichens is the highest [23].
Furthermore, the amount of several TE dissolved in Etna ground
waters is also significantly higher in the eastern and southern
sectors of the volcano. This effect, however, is not directly related
with TE deposition from the volcanic plume, but rather it is due to
direct input of soluble magmatic gases from depth into the water
table through the many deep faults that cross the above sectors of
the volcanic edifice and allow flank leakage of magmatic volatiles
to the surface [24–25]. Therefore, if TE have a role in the
pathogenesis of MS, a higher incidence is expected among the
populations located in the eastern and southern flanks of the
volcano, whereas a lower incidence is expected in the populations
located in its western flank, less exposed to crater gas emissions. In
order to test this hypothesis we carried out an ecological survey
aimed at determining the prevalence and incidence of MS in two
populations respectively located in the eastern and western flanks
of Mount Etna.
Materials and Methods
Ethics statement
The study was approved by local ethical committee (Azienda
Universitaria-Ospedaliera Policlinico Vittorio Emanuele, Catania)
and patients were enrolled after they signed an informed consent.
Study area
In order to evaluate the possible link between TE and MS in the
Mount Etna area, we assessed the prevalence and incidence of MS
among populations most exposed to volcanogenic TE released
both through its crater gas plume and through the faults crossing
its volcanic edifice, that is those located in its east flank. We also
evaluated the prevalence and incidence of MS in populations
much less exposed both to crater gas emissions and to TE contents
in groundwater, such as those located in the west flank of Mt Etna.
Communities belonging to the two categories above and with a
stable population over the time, have been selected according to
previous geochemical studies. In particular we have selected an
overall population of about 50,000 inhabitants in the most exposed
area (east flank of Mount Etna) and a population of similar size for
the least exposed area (west flank of Mount Etna).
Finally we selected four communities from the east flank
(Giarre, Santa Venerina, Sant’Alfio and Zafferana) and two
communities (Adrano and Bronte) from the west flank. Consid-
ering the last official census (census 2011) [26], the overall
population of the communities selected in the eastern flank was
47,229 inhabitants, while that of the communities selected in the
western flank was 56,216. According to census data, population in
all of the selected communities was quite stable during the last 30
years (census 2011) [26]. Age and sex distribution of the study
population (census 2011) is shown in figure 1.
Case ascertainment
The primary sources of MS data investigated were the
Neurological hospitals of Catania (Neurological Clinic and MS
center of the University of Catania, the Neurological Division and
the MS center of the Garibaldi Hospital and the Neurological
Division and the MS center of the Cannizzaro Hospital). MS
centers in the province of Messina have been also checked. We
also requested the list of all the enrolled members of the Italian
Multiple Sclerosis Association (AISM).
We further revised the archives until to the end of June 2012 to
detect those patients who had their clinical onset of MS during the
decade 2000–2009, but who fulfilled the diagnostic criteria only
after the study period. Written consent was given by the patients
for their information to be stored in the hospital database and used
for research. A code has been attributed to each identified cases
before the data entry. We verified all sources at least twice. All
surviving potential patients with MS identified from these sources,
except those attending our neurological department and MS
center, were called to undergo neurological examination per-
formed by trained neurologists of our team in order to confirm the
diagnosis. Data on deaths were derived from the official ‘‘deaths
register’’ of the city of Catania. In order to minimize potential
sources of error during data collection, we selected a team of
neurology residents who spent at least one month at the MS center
and who were previously trained for data abstraction. Information
was collected on pre-coded forms created ad hoc and revised by a
supervisor. Data were checked for consistency and any error found
was corrected.
Diagnostic criteria
In order to allow comparison with previous surveys [14] and
literature data, case definition for the incidence and prevalence
estimates was based on Poser’s diagnostic criteria [27]. All patients
who satisfied these criteria for clinically definite MS (CDMS),
laboratory-supported definite MS (LSDMS), clinically probable
MS (CPMS) and laboratory-supported probable MS (LSPMS)
were considered as prevalent and incident cases.
When available, the onset was established using objective data
or the history was obtained interviewing patients and their closest
relatives. Prevalence was based on the number of patients who
were living in the study area on prevalence day December 31,
2009, and had the clinical onset while living there (onset-adjusted
prevalence rate). Crude prevalence rate was age-adjusted to the
Italian population (national census 2011) direct method of
standardization.
Incidence risk was studied for the three ten-year intervals from
1980 to 2009. Incidence risk was based on the year of the clinical
onset (onset-adjusted incidence risk). Confidence intervals for
estimates were calculated assuming a Poisson’s distribution. For
each studied decades incidence risks were also sex and
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age-adjusted to the Italian population (national census 2011) using
the direct method of standardization.
Relative Risk (RR) for each decades were also estimated
considering the eastern population as the exposed population and
the western population as the unexposed one.
Results
At the end of the case finding, a total of 118 MS patients
fulfilling the Poser’s diagnostic criteria were identified in the study
areas. In particular 109 (93%) fulfilled the criteria for defined MS
(clinically or laboratory supported) while nine (four in the western
flank and five in the eastern one) where classified probable MS.
Nevertheless all the identified MS patients underwent at least one
MRI examination all showing white matter lesions compatible
with MS.
Prevalence
On the prevalence day (January 1, 2009), we detected 53 MS
patients (13 men and 40 women) who were resident in the
communities located in the western flank of Mount Etna (Adrano
and Bronte) and who had experienced the clinical onset of the
disease. For this area the onset-adjusted prevalence rate (53 cases
with onset before the prevalence day) was 94.3/100,000 (95% CI
68.7–119.3). Age-adjusted prevalence to the Italian population
(census 2011) was 100,7/100,000. Overall, the prevalence was
higher in women (137.3/100,000; 95% CI 99.4–188.9) than in
men (48.0/100,000; 95% CI 26.7–84.4).
On the other hand, in the eastern flank communities (Giarre,
Santa Venerina, Sant’Alfio and Zafferana), considered the highly
exposed area to input of TE, we detected 65 MS patients (20 men
and 45 women) who had experienced the clinical onset of the
disease on prevalence day. For the eastern area the onset-adjusted
prevalence rate was 137.6/100,000 (95% CI 104.5–171.5). Age-
adjusted prevalence to the Italian population (census 2011) was
137,8/100,000. Again, the overall prevalence was higher in
women (230.3/100,000; 95% CI 170.5–305.3), than in men (72.2/
100,000; 95% CI 45.3–113.7).
Point-prevalence in the eastern flank population was higher
than that in the western flank population (respectively, 137.6/
100.000 and 94.3/100,000; p-value 0.04). Both in the eastern and
in the western areas age-specific prevalence increased in the first
age groups, with a peak in the group aged 35–44 (317.7/100,000
and 216.7/100,000 respectively) and it showed a steep decline in
the other groups.
In the western flank population, the mean age at onset was
29.269.5 years, with a mean disease duration of 12.668.1 years,
whereas in the eastern flank population the mean age at onset was
30.2610.6 years with a mean disease duration of 13.569.3 years.
None of the 118 identified MS patients reported some kinship
up to the second-degree relatives (grandparents).
Incidence
During the incidence study period (1980–2009) 51 MS patients
(13 men and 38 women) living in the western area of the Mount
Etna had the clinical onset of the disease. During the incidence
study period the average population in the western area was
52,561 (25,724 men and 26,837 women). The average annual
onset-adjusted incidence was 3.2/100,000 (95% CI 2.4–4.2), 2.8/
100,000 sex and age-adjusted to the Italian population. Incidence
was 4.7/100,000 (95%CI 3.3–6.4) for women and 1.7/100,000
(95% CI 0.9–2.9) for men. In the western flank population the
incidence risk increased from 1.0/100,000 (95% CI 0.3–5.6)
during 1980–1989 to 4.2/100,000 (95% CI 2.6–6.5) during 1990–
1999, then remaining quite stable during the following decade
2000–2009 (4.4/100,000; 95%CI 2.8–6.5).
Concerning the eastern flank population, from January 1980 to
December 2009, 59 MS patients (19 men and 41 women) had the
clinical onset of the disease. During the incidence study period, the
average population in the eastern flank area was 43,797 (23,511
men and 20,284 women). The average annual onset-adjusted
incidence was 4.6/100,000 (95% CI 3.1–5.9), 3.9/100,000 sex and
age-adjusted to the Italian population. Incidence was 6.7/100,000
(95%CI 4.8–9.1) for women and 2.7/100,000 (95% CI 1.6–4.2)
for men. In the population living on the eastern flank of Mount
Etna the incidence risk increased from 1.7/100,000 (95%CI 0.7–
3.5) during 1980–1989 to 5.5/100,000 (95%CI 3.5–8.1) during
1990–1999, reaching a peak of 6.4/100,000 (95%CI 4.3–9.1)
during the decade 2000–2009.
Average annual incidence risk for 10-year intervals from 1980
to 2009 both for the western flank and for the eastern flank
populations are shown in table 1 and figure 2. We found a
borderline significantly higher incidence risk during the incidence
study period (1980–2009) in the population located in the eastern
flank of Mount Etna, compared with the population located in the
western flank (RR 1.41; 95% CI 0.97–2.05; p-value 0.06). In
particular, the risk ratio (RR) for the first decade (1980–1989) was
1.69 (95% CI: 0.54–5.32; p-value 0.3), it was 1.32 (95% CI: 0.74–
2.35; p-value 0.3) for the second decade (1990–1999), while it was
1.45 (95% CI: 0.84–2.48; p-value 0.1) for the last decade (2000–
2009).
Overall the mean length of time between the date of
clinical onset and the date of diagnosis significantly decreased
from 6.966.2 years during 1980–1989 to 3.563.5 years during
Figure 1. Age and sex distribution of the study population (census 2011).
doi:10.1371/journal.pone.0074259.g001
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1990–1999 and 2.662.4 years during 2000–2009. The female-to-
male ratio for the entire incidence study period was 2.77 in the
western flank (95% CI 1.47–5.19; p-value 0.0009) and 2.50 in the
eastern one (95% CI 1.45–4.30; p-value 0.0006). Age at onset
steeply increased from 22.268.3 years during 1980–1989 to
29.769.1 years during 1990–1999 and 31.8610.7 years during
the last decade without significant difference between the two
flanks. Out of the 118 MS patients, 9 (1.7%) had had the onset
before the age of 10 (5 in the western flank and 4 in the eastern
one).
Discussion
In the city of Catania, incidence has been increasing dramat-
ically during the last 30 years, from 1.3/100,000 during the period
1975–1979 to 7.0/100,000 during the period 2000–2004 [14].
This figure is close to the incidence reported in Sardinia [6,11],
where probably a different genetic background contributes to the
elevated MS risk, but it is higher than those recently reported for
continental Italy [4,5,8,9,10]. Considering that the population of
Catania is ethnically stable, the increasing incidence over the time
during the last 30 years strongly suggests a change in the exposure
to one or more exogenous causative factors for MS over time.
MS is a complex disease that is due to interactions between
genes and environmental factors that lead to tissue injury by
autoimmune mechanisms. The environment influences MS risk at
a population level. Important environmental factors include
sunlight exposure, vitamin D status, smoking and infections. Of
the infectious agents linked to MS, epidemiological evidence
currently supports a role for EBV infection in the pathogenesis
[28].
Literature provides evidence of a possible role of environmental
and occupational factors such as exposure to organic solvents, to
Zn used in manufacturing plant, to Ba contaminant in the
ecosystems or presence of Co, Mn, Mo and Zn in arable soils [29–
32]. Furthermore, several trace or major elements have been
investigated and increased levels of Cd, Cu, Fe and Pb, together
with a decrement of Mg and Zn, have been reported among MS
patients [33]. Additional studies have shown variations in Cu, Mg
and Zn concentrations in serum and cerebrospinal fluids from
patients affected by MS [34,35]. Studies performed so far
highlighted the possible role of TE into the MS pathogenesis
and disease development without allowing definitive conclusions
about the exact relationship between metals and the pathology.
Alterations in metal homeostasis might result in an increased
level of free radicals [36]. A large body of evidence implicates
crucial roles of oxidative stress in the pathogenesis of several
neurodegenerative disorders including MS [37]. The progressive
myelin destruction may be accelerated by oxidative stress and
metals in fact may exert or aggravate toxic effects on myelin. Toxic
effects are of course more likely with long-term overexposure [38].
On the other hand cytokines production can be influenced by
various chemicals and among metal Ni, Cr, Cd, Co and Hg are
especially known to influence immunocompetent cells [39].
For instance exposure to Ni compounds can have adverse effects
on human health [40]. The possible role of Ni in inducing
oxidative stress has been well demonstrated in animal model and it
has been also demonstrated that endothelial surface molecules
(such as ICAM-1 and VCAM-1) are upregulated by NiCl2
exposure in cultured human cells [40].
Natural sources of heavy metals can play an important role and
active volcanoes release considerable amounts of metals and
semimetals as the result of their very high volatility in high
temperature magmatic vapours [19]. Mt. Etna is the largest active
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volcano in Europe, emitting about 16% of the global volcanic
heavy metals (including nickel, cadmium, lead) and 19% alkali
metals (including sodium, potassium, lithium) during eruptions
and less than 5% during quiet periods [41]. It should be noted
that, for example, Mount Etna emits about 100 tons/year of Ni
[19]. The general population is mainly exposed to Ni through food
intake and inhalation from the air and a possible additive source of
Ni exposure in the local population may come from the emission
of Ni in the soil or in the volcanic plume or ashes [19].
Furthermore, volcanic activity at Mt. Etna has increased
significantly during the last decades [21,22], both in terms of
frequency of eruptions and in terms of lava emission rate, thus
releasing a huge amount of TE in the environment.
The almost concurrent increase both of MS cases and of
frequency of eruptions gives rise to a first assumption of a possible
correlation between the two phenomena. Due to the higher
exposure of the populations living on the eastern flank of the
volcano compared to those living on its western flank, it is
expected to find a higher occurrence of MS in the former than in
the latter. In agreement with our hypothesis, a higher frequency of
MS, both in terms of prevalence and incidence, has been recorded
in the populations located on the eastern flank of Mount Etna.
Actually, the incidence risk found in the eastern flank populations
is close to that reported in the city of Catania (7.0/100,000), that is
also located in the eastern-southern area. Conversely, the
incidence risk found in the populations located on the western
flank (4.4/100,000 during the last decade) is close to those recently
reported for continental Italy [4,5,8,9,10].
Nevertheless it should be noted that incidence mainly increased
in both flanks from the first to the second decade (from 1.0/
100,000 to 4.2/100,000 in western flank and from 1.7/100,000 to
5.5/100,000 in eastern flank). This change in temporal trend could
be considered the effect of improvement in diagnostic techniques
and medical facilities as reflected by the shortened lagtime during
the same period (from 6.966.2 to 2.662.4 years). In our
population the mean age at onset increased steadily over the
incidence study-periods from a mean of 22.268.3 to 31.8610.7. A
similar trend has been already observed by our group in the city of
Catania as well as in Sardinia [11]. In agreement with literature
data female-to-male ratio over the entire study period was 2.7
without significant differences in both flanks [2]. However it
should be noted that incidence estimates for each single stratum
(by decade and sex) could be affected by random variation related
to the small number of events and for this reason further stratified
analysis could produce not reliable estimates.
Ecological studies look for associations at the group level rather
than at the individual level and, therefore, we do not have
information on the outcome status of exposed versus non-exposed
individuals within the same group. However, several limits related
to the ecological design should be taken into consideration in the
interpretation of our findings. Ecological studies are particularly
susceptible to information bias, therefore detecting and controlling
confounding factors can be extremely difficult. Several factors are
in fact more strongly associated with each other at the group level
than they are at the individual level. If the exposure we are
studying is highly correlated with a potential confounder, it can be
difficult or even impossible to separate out the effect of exposure
alone. Groups usually differ in many factors and it can be very
difficult to judge which factor is responsible for differences in
outcomes between groups. For this reason we have compared
groups selected from the same province (i.e., that of Catania) that
are quite similar (in terms of genetic background, UV exposition,
lifestyle, diet, etc.), except for the exposure of interest (in this case,
exposure to TE).The main weakness of an ecological study is the
so called ‘‘ecological fallacy’’. In this respect, ecological studies
may allow to make ecological inferences about effects at the group-
level, but they do not enable us to make inferences about
individual risks. On the other hand, ecological studies can often be
carried out in a relatively quick and cheap way, using routine or
Figure 2. Average annual onset/adjusted incidence risk of MS in the populations of the western and eastern flanks of Mount Etna
during the incidence study period.
doi:10.1371/journal.pone.0074259.g002
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secondary data and they can be used as a first step in the
investigation of a possible exposure-outcome relationship.
Nevertheless, despite the evidence supporting the possible
association between TE and MS, the reported excess MS cluster
in the small town of Linguaglossa on the lower north flank of the
volcano [42,43] and the proven presence of elevated levels of
certain TE in the Mount Etna region, this study represents the first
attempt to investigate the possible direct link between exposure to
volcanogenic TE and occurrence of MS in this region.
The aetiology of MS is still unknown. Genetic, environmental
and immunological factors (smoking, viruses, vitamin D etc.), have
been implicated in the aetiology of this complex, multifactorial and
heterogeneous disease and in this scenario it is also possible that the
chronic exposure to high levels of TE can play a role. We are
aware that other hidden causes of human exposure to TE are
present in everyday life, therefore the study of a ‘‘natural model’’
of volcanic heavy metals emission in the environment could
represent an important source of information, complementary to
the broader and widespread model represented by industry-related
TE.
In conclusion, according to our data a possible role of TE
cannot be ruled out as possible co-factor in the MS pathogenesis.
However larger epidemiological study are needed to confirm our
results and population-based case control studies focused on
measuring the TE levels in biological samples should be performed
in order to strengthen this hypothesis.
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